About this episode
Why Eli Lilly and Novo Nordisk are headed for weight loss riches. And a top strategist shares moves to make now.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Barron's Streetwise publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Barron's Streetwise
Roller Coasters, REITs, and Rotten Tomatoes
Barron's Streetwise
Sep 4, 202633:52completed
Will Bond Vigilantes Tank the Stock Market?
Barron's Streetwise
Aug 28, 202631:04pending
Oracle and Oil Refiners. Plus, Pyramid Scheme or Nah?
Barron's Streetwise
Aug 21, 202625:39pending
Ode to BJ’s Wholesale
Barron's Streetwise
Aug 14, 202629:18pending